IMI CLINICAL SUMMARIES

Defining and classifying myopia report

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Daniel Ian Flitcroft MB.BS. D.Phil
IMI Committee Chair
Children’s University Hospital, University College Dublin and Dublin Institute of Technology, Ireland

Experimental Models of Emmetropization and Myopia

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Earl L. Smith III OD, PhD
IMI Committee Chair
College of Optometry, University of Houston, Houston, TX, USA

David Troilo PhD
IMI Committee Chair
SUNY College of Optometry, State University of New York, New York, NY, USA

Myopia Genetics

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Milly Tedja MD
IMI Committee Member
Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands

Caroline Klaver MD, PhD
IMI Committee Chair
Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands

Interventions for Myopia Onset and Progression

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Christine F. Wildsoet DipAppSci (Optom), BSci (Hons Pharm), PhD
Committee Chair IMI
Berkeley Myopia Research Group, School of Optometry & Vision Science Program,
University of California Berkeley, Berkeley, CA, USA

Clinical Myopia Control Trials and Instrumentation

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

James S. Wolffsohn FCOptom PhD
IMI Committee Chair
Ophthalmic Research Group, Aston University, Birmingham, UK

Industry Guidelines and Ethical Considerations for Myopia Control

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Lyndon Jones PhD, FCOptom
IMI Committee Chair
Centre for Ocular Research & Education (CORE),
School of Optometry & Vision Science, University of Waterloo, Waterloo, Canada.

Clinical Myopia Management Guidelines

CLINICAL SUMMARY

Monica Jong PhD, BOptom
IMI Executive Director
Brien Holden Vision Institute Sydney, Visiting Fellow School of Optometry and Vision Science,
University of New South Wales, Sydney, Australia.

Kate L. Gifford BAppSc(Optom), PhD
IMI Committee Chair
Private Practice and Queensland University of Technology, Australia

Translation

We would like to acknowledge the translators who have helped to further disseminate the IMI white paper findings around the world in the following languages:

Spanish  | Dr Luisa Cassaluqe OD PhD, BHVI Sydney
French | Ornella Koumbo  OD PhD Candidate, BHVI Sydney
Chinese | Nicole Xiao Liu MOptom PhD Candidate, BHVI Sydney
Nepalese | Dr Safal Khanal OD PhD, SOVS, University of Auckland, NZ